NCCN Guidelines Insights: Antiemesis, Version 2.2017

J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.

Publication types

  • Practice Guideline

MeSH terms

  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzodiazepines / therapeutic use
  • Granisetron / therapeutic use
  • Humans
  • Neoplasms / complications
  • Neoplasms / therapy
  • Olanzapine
  • Serotonin Antagonists / therapeutic use
  • Vomiting / drug therapy*
  • Vomiting / etiology
  • Vomiting / prevention & control

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Serotonin Antagonists
  • Benzodiazepines
  • Olanzapine
  • Granisetron